Global needle-free injection system market is expected to reach USD 42.63 Billion by 2026 and set to witness a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to extensive use of needle-free injection system in the developing countries.

Market Drivers

Increasing number of chronic disease is expected to drive the growth of the market in the forecasted period

Increased rate of communicable disease due to needle stick injuries is expected to drive the growth of the market Increasing demand for self-injection devices is expected to increase growth of the market in the forecasted period

Increasing demand for biosimilars and vaccination is expected to enhance growth of the market

Click Here to Get Latest Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Market Restraints

Limitation in intravenous administration is expected to restrain the market growth

Stringent regulation is expected to hinder the market growth

Needle-free injection system is costly which is expected to restrain the market growth

Key Developments in the Market :

In July 2019, Eli Lilly and Company has received U.S. Food and Drug Administration approval for Baqsimi (glucagon) nasal powder 3 mg. The product is used to treat diabetic severe hypoglycemia. The product approval will help company to increase its revenue generation from drug delivery system as the product is first of its kind and only nasally-dosed glucagon, available for diabetics

In January 2018, LenisUSA.com and Lenis Medical Ltd has formed partnership with Premier Media Service Inc. for distribution and sales of LENIS Needle-Free Injection System in U.S. The injection system is a next generation needle free injections system and the device is highly adaptable, and applicable to anesthetics, steroids, HA, HGH, HCG, MS drugs, vitamins, insulin, vaccines, filers, fertility drugs, and orthopedic drugs. The partnership will help company to increase its market presence in U.S.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-needle-free...

Key Players –

Antares Pharma, Endo Pharmaceuticals Inc., PharmaJet, Inovio Pharmaceuticals, Inc., Medical International Technologies, INJEX, THE NATIONAL MEDICAL PRODUCTS CO., LTD, Valeritas, Inc., InsuJet, PenJet, Crossject, Amico Group, BD, Inovio Pharmaceuticals, Inc., MedImmune, Mystic Pharmaceuticals, OptiNose US, Inc., Zogenix, D’Antonio Consultants International, Inc., among others.

MAJOR TOC OF THE REPORT

Part One: Needle-Free Injection System Market Overview

Part Two: Manufacturers Profiles

Part Three: Global Needle-Free Injection System Market Competition, by Players

Part Four: Global Needle-Free Injection System Market Size by Regions

Part Five: Global Needle-Free Injection System Market Revenue by Countries

Part Six: Global Needle-Free Injection System Market Revenue by Type

Part Seven: Global Needle-Free Injection System Market Revenue by Application

Part Eight: Global Needle-Free Injection System Market Revenue by Geography

Part Nine: Global Needle-Free Injection System Market Revenue by Geography

Part Ten: Global Needle-Free Injection System Market Revenue by Geography

Part Eleven: Global Needle-Free Injection System Market Revenue by Geography

Get Detail TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-needle-fr...

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports @

Global Contrast and Imaging Agents in Interventional X-Ray Market

Global Fibrinogen Testing Market

Global Dental Prosthetics Market